This company has been marked as potentially delisted and may not be actively trading. Flex Pharma (FLKS) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock FLKS vs. VHAQ, PYRGF, ATNM, OSTX, AADI, NBRV, EGRX, ELYM, MRNS, and ALLKShould you be buying Flex Pharma stock or one of its competitors? The main competitors of Flex Pharma include Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), Actinium Pharmaceuticals (ATNM), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), Eagle Pharmaceuticals (EGRX), Eliem Therapeutics (ELYM), Marinus Pharmaceuticals (MRNS), and Allakos (ALLK). Flex Pharma vs. Its Competitors Viveon Health Acquisition PyroGenesis Canada Actinium Pharmaceuticals OS Therapies Aadi Bioscience Nabriva Therapeutics Eagle Pharmaceuticals Eliem Therapeutics Marinus Pharmaceuticals Allakos Flex Pharma (NASDAQ:FLKS) and Viveon Health Acquisition (NYSE:VHAQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment. Does the media favor FLKS or VHAQ? In the previous week, Flex Pharma's average media sentiment score of 0.00 equaled Viveon Health Acquisition'saverage media sentiment score. Company Overall Sentiment Flex Pharma Neutral Viveon Health Acquisition Neutral Do insiders and institutionals believe in FLKS or VHAQ? 14.4% of Flex Pharma shares are owned by institutional investors. Comparatively, 22.1% of Viveon Health Acquisition shares are owned by institutional investors. 7.6% of Flex Pharma shares are owned by company insiders. Comparatively, 75.3% of Viveon Health Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is FLKS or VHAQ more profitable? Viveon Health Acquisition has a net margin of 0.00% compared to Flex Pharma's net margin of -1,208.42%. Viveon Health Acquisition's return on equity of 0.00% beat Flex Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Flex Pharma-1,208.42% -98.04% -83.37% Viveon Health Acquisition N/A N/A N/A Which has more risk & volatility, FLKS or VHAQ? Flex Pharma has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Viveon Health Acquisition has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500. Which has stronger valuation and earnings, FLKS or VHAQ? Viveon Health Acquisition has lower revenue, but higher earnings than Flex Pharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlex Pharma$840K19.11-$21.92MN/AN/AViveon Health AcquisitionN/AN/A-$610KN/AN/A SummaryViveon Health Acquisition beats Flex Pharma on 6 of the 8 factors compared between the two stocks. Get Flex Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLKS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLKS vs. The Competition Export to ExcelMetricFlex PharmaPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.05M$790.61M$5.49B$9.02BDividend YieldN/A4.84%5.38%4.10%P/E RatioN/A1.3227.4720.28Price / Sales19.11226.97408.86121.46Price / CashN/A23.4436.6357.47Price / Book1.746.288.095.68Net Income-$21.92M-$27.84M$3.17B$248.96M Flex Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLKSFlex PharmaN/A$0.89-1.2%N/A-62.9%$16.05M$840K0.004Gap DownVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumePYRGFPyroGenesis Canada0.0922 of 5 stars$0.33-5.5%N/A-36.9%$60.86M$9.14M-5.4390High Trading VolumeATNMActinium Pharmaceuticals2.5116 of 5 stars$1.70+11.8%$4.00+135.3%N/A$53.03M$81K-1.2230OSTXOS Therapies2.7089 of 5 stars$1.72+1.2%$18.00+946.5%N/A$48.33MN/A-2.00N/ANews CoverageGap UpHigh Trading VolumeAADIAadi Bioscience0.6722 of 5 stars$1.95-6.7%$1.67-14.5%+34.3%$48.16M$25.07M-0.8640News CoverageNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070EGRXEagle PharmaceuticalsN/A$2.75-1.4%N/A-45.5%$35.71M$257.55M0.00100Gap DownELYMEliem TherapeuticsN/A$1.20-0.8%N/A-81.6%$35.70MN/A-2.269MRNSMarinus Pharmaceuticals2.3853 of 5 stars$0.55-0.2%$3.92+613.3%-54.6%$30.32M$30.99M-0.22110ALLKAllakos2.9099 of 5 stars$0.33flat$2.00+507.7%N/A$29.74MN/A-0.16190 Related Companies and Tools Related Companies Viveon Health Acquisition Competitors PyroGenesis Canada Competitors Actinium Pharmaceuticals Competitors OS Therapies Competitors Aadi Bioscience Competitors Nabriva Therapeutics Competitors Eagle Pharmaceuticals Competitors Eliem Therapeutics Competitors Marinus Pharmaceuticals Competitors Allakos Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLKS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flex Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Flex Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FLKS Stock Alerts